multiple sclerosis

Know the benefits of adopting neuroimaging
Know the benefits of adopting neuroimagingNeuroimaging can help ODs better treat patients with possible tumor, vascular disorder, or demyelinating disease. CT scans are used for bone fractures and vascular disorders as well as orbital and pituitary tumors. MRIs are best gliomas and menigiomas and screening for vascular disorders. Communicate to radiology patient history and what you are trying to rule out when ordering tests.
Specialty drug pipeline predictions: Seven key areas to watchThe specialty drugs market will see more approvals in 2017 than 2016. Top areas to watch include cancer, multiple sclerosis, and HIV.
Ocrelizumab for Multiple Sclerosis
Ocrelizumab for Multiple SclerosisThe FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
Medical marijuana update: Top 3 things health execs should knowHere’s what you need to know about medical marijuana laws, and what they mean for the healthcare system.
FDA approves Bayer’s Bluetooth-enabled auto-injector for multiple sclerosisFDA has approved a supplemental Biologics License Application (sBLA) for Bayer’s myBETAapp and BETACONNECT Navigator for multiple sclerosis (MS) patients
10 More Newly Approved Drugs
10 More Newly Approved DrugsWhat you need to know about the the 10 newest FDA drug approvals.
Integrating pharmacy benefit, medical benefit cuts costsHere’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.
Copay assistance programs: Managed care pros and consDo copay assistance program offer a long-term solution for patients? Experts weigh in.
FDA approves Zinbryta to treat multiple sclerosisFDA recently approved daclizumab (Zinbryta, Biogen and AbbVie), a once-monthly, self-administered, subcutaneous treatment for relapsing forms of multiple sclerosis (RMS).
Electronic prior authorization and payers: Lessons from BCBSTwo presenters at the AMCP 2016 conference examine a Blue Cross and Blue Shield of Michigan pilot project to leverage technology for its medical specialty drug management program. Here are the lessons learned.